(1) In this section: (a) "Anti-epileptic drug" means: (i) A drug used for the treatment of epilepsy; or (ii) A drug used to treat or prevent seizures. (b) "Drug product selection" means the selection of a therapeutically equivalent drug, including a generic version for the prescribed brand, a branded version for the prescribed generic, a generic version by one (1) manufacturer for a generic version by a different manufacturer. (c) "Epilepsy" means a neurological condition characterized by recurrent seizures. (d) "Seizure" means an acute clinical change secondary to a brief disturbance in the electrical activity of the brain. (2) When a prescriber has specified that a drug is prescribed for the treatment of epilepsy or seizures, pharmacy personnel who perform drug product selections shall: (a) Notify the prescriber of such drug product selection via facsimile, telephone message or any other appropriate means to the prescriber’s place of business; and (b) Provide the patient or the patient’s representative with notification of the selection. (3) Nothing in this section shall delay the dispensing of a valid prescription for an anti-epileptic drug.
‹ Prev All Idaho sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.